Smith+Nephew’s T.I.M.E. CDST launch judged Most Innovative at the 2020 Gartner Communications Awards

Advertisement

BEGIN ARTICLE PREVIEW:

LONDON, Sept. 16, 2020 /PRNewswire/ — Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today welcomes the announcement that its campaign to develop and promote the T.I.M.E. clinical decision support tool (CDST)1 was awarded Most Innovative in the category Excellence in Reputation & Thought Leadership at the 2020 Gartner Communications Award Ceremony. The campaign was chosen among 200 entries from organisations across 30 countries.
Smith+Nephew’s campaign addressed the finding that 40% of wound care specialists did not routinely use wound assessment tools leading to considerable variability in clinical practice.2
“To help improve consistency in front line wound care, we developed the T.I.M.E. CDST, a simple 5-step framework that applies the principles of wound bed preparation as part of holistic patient care. We ensured clinical relevance by involving international clinical expert practitioners throughout the 3-step development process of 1)  identifying the issue of variation in practice 2) developing, validating and launching the tool and 3) providing proof of concept by implementation in daily practice.” said the programme leader, Claudia Matei, Global Marketing Director, Smith+Nephew.
The KOL-endorsed two-year programme has produced outstanding customer engagement. The clinical experts delivered eight publications, and the learnings and recommendations have been written up in a …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE